Table 1 Demographic and clinical characteristics of the sample (N = 124)
Variable | Mean ± SD | Frequency (%) | Median (1st, 3rd quartile) |
|---|---|---|---|
Age (years) | 55.4 ± 7.9 | ||
Gender | |||
Female | 69 (55.6%) | ||
Male | 55 (44.4%) | ||
Onset, months | 6.9 ± 4.7 | ||
Shoulder affected | |||
Left | 68 (54.8%) | ||
Right | 56 (45.2%) | ||
Dominant arm | |||
Right | 112 (90.3%) | ||
Left | 12 (9.7%) | ||
Occupation | |||
Employed | 66 (53.2%) | ||
Self-employed | 39 (31.5%) | ||
Retired | 14 (11.3%) | ||
Housewife | 5 (4.0%) | ||
Comorbidities | |||
Diabetes | 13 (10.5%) | ||
Hypertension | 9 (7.3%) | ||
Thyroid pathologies | 7 (5.6%) | ||
Hearth diseases | 3 (2.4%) | ||
Autoimmune diseases | 2 (1.6%) | ||
Rheumatological pathologies | 2 (1.6%) | ||
Epilepsy | 2 (1.6%) | ||
Migraine | 1 (0.8%) | ||
Chronic gastritis | 1 (0.8%) | ||
Hypercholesterolemia | 1 (0.8%) | ||
Hyperglycemia | 1 (0.8%) | ||
Prostatic hypertrophy | 1 (0.8%) | ||
Pulmonary tumor | 1 (0.8%) | ||
Osteoporosis | 1 (0.8%) | ||
Extrapyramidal syndrome | 1 (0.8%) | ||
Hormone therapy | 1 (0.8%) | ||
Leukocytoclastic vasculitis | 1 (0.8%) | ||
None | 76 (61.3%) | ||
DASH | 39.5 (25.0, 52.0) | ||
NPRS | 7.0 (5.0, 8.0) | ||
SPADI | |||
Pain subscale | 59.0 (38.5, 76.0) | ||
Disability subscale | 50.5 (30.0, 70.0) | ||
SF-36 | |||
PCS | 41.2 (36.6, 46.0) | ||
MCS | 40.1 (22.3, 50.5) |